Loading...

SNOA SONOMA PHARMACEUTICALS INC Delisting Actions 8-K Filing

SNM

SN

SONOMA PHARMACEUTICALS INC

(SNOA)

2024 8-K

Summary

Summary

Management Changes

Investor Presentation Update

Stock Sale Agreement

Annual Meeting Results

Investor Presentation

Investor Presentation

Supply Agreement Update

Supply Agreement

Agreement Termination

Distribution Agreement

Equity Distribution

Stock Split Approval

Distribution Agreement

Equity Distribution Agreement

Investor Presentation

Investor Conferences

Delisting Notice

Equity Distribution Agreement

Regulation FD Disclosure

Agreement with NovaBay Phar...

Stock Options Grant

Equity Distribution Agreement

Amendment to Form 8-K

Investor Presentation

Investor Presentation

Management Changes

Amendment to At-The-Market ...

Distribution Agreement

Investor Presentation

External Links:

Sonoma Pharmaceuticals, Inc. received a notice from Nasdaq granting them an additional 180 days to regain compliance with the minimum closing bid price requirement for continued listing on The Nasdaq Capital Market.

AI Assistant

SONOMA PHARMACEUTICALS INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.